112
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?

, , , , &
Pages 287-294 | Published online: 23 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Emanuela Teveroni, Rossella Lucà, Marsha Pellegrino, Germana Ciolli, Alfredo Pontecorvi & Fabiola Moretti. (2016) Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review. Expert Opinion on Therapeutic Patents 26:12, pages 1417-1429.
Read now

Articles from other publishers (4)

Ni Pi, Meng Gao, Xiyao Cheng, Huili Liu, Zhengkun Kuang, Zixin Yang, Jing Yang, Bailing Zhang, Yao Chen, Sen Liu, Yongqi Huang & Zhengding Su. (2019) Recombinant Butelase-Mediated Cyclization of the p53-Binding Domain of the Oncoprotein MdmX-Stabilized Protein Conformation as a Promising Model for Structural Investigation. Biochemistry 58:27, pages 3005-3015.
Crossref
Duncan Ayers & Jo Vandesompele. (2017) Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance. Genes 8:3, pages 95.
Crossref
Michael P. Dickens, Patricia Roxburgh, Andreas Hock, Mokdad Mezna, Barrie Kellam, Karen H. Vousden & Peter M. Fischer. (2013) 5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2. Bioorganic & Medicinal Chemistry 21:22, pages 6868-6877.
Crossref
Duncan Ayers & Alessandro Nasti. (2012) Utilisation of Nanoparticle Technology in Cancer Chemoresistance. Journal of Drug Delivery 2012, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.